CN101361902A - Traditional Chinese medicine granules for treating coronary heart disease - Google Patents
Traditional Chinese medicine granules for treating coronary heart disease Download PDFInfo
- Publication number
- CN101361902A CN101361902A CNA2008100134299A CN200810013429A CN101361902A CN 101361902 A CN101361902 A CN 101361902A CN A2008100134299 A CNA2008100134299 A CN A2008100134299A CN 200810013429 A CN200810013429 A CN 200810013429A CN 101361902 A CN101361902 A CN 101361902A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese
- heart disease
- coronary heart
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese patent medicine, in particular to a Chinese granule medicine for curing coronary heart disease. The Chinese granule medicine is characterized by comprising the following Chinese medicinal components: ginseng, rizoma polygonatum, licorice root, cassia twig, polygonatum, astragalus, panax notoginseng, root of red rooted salvia, radix puerariae, chrysanthemum and plantain seeds. The Chinese granule medicine is purely prepared from natural Chinese medicinal materials, with reasonable proportions, is proved to be nontoxic and safe to human bodies without side effects. The Chinese granule medicine is tried by clinical patients and shows noticeable curative effects in curing high blood pressure, heart diseases and coronary heart disease, with a cure rate of 98 percent.
Description
One, technical field:
The present invention relates to the field of Chinese medicines.
Two, background technology:
Coronary heart disease is rejuvenation development day by day in recent years, and quantity is rising year by year, it is a kind of clinical syndrome of feel, modern medicine study is thought: coronary heart disease mainly is under various effects of actuating pulse atherosclerosis, cause that atheromatous plaque gathers under the coronary endometrium, long-run development, it is big that speckle becomes gradually, so that break and cause thrombosis, cause chronic or acute myocardial ischemia, anoxia.The method of treatment coronary heart disease mainly contains at present: adopt western medicine therapies such as chemical synthetic drug, coronary artery bypass grafting, intervention, its clinical efficacy is higher, side effect was also bigger when but the disease of preventing or cure a disease was fast, particularly big especially to side effect such as liver, kidneys, influence rehabilitation of patients, and the most important thing is and fundamentally to cure.
Chinese medicine thinks that then it is obstructed that the cause of disease of coronary heart disease is mainly blood vessels, and blood vessels are obstructed to be because blood stasis and expectorant foul smell stagnate, and the generation of the stasis of blood, expectorant, the stagnation of QI is the result of visceral dysfunction for a long time.The Chinese Traditional Medicines of therefore treating coronary heart disease are also fast-developing, extensively approved in the curative effect of improving aspect such as coronary heart disease clinical symptoms.But still there is certain not enough problem in present Chinese patent medicine, mainly is to be still waiting in the unification of toxic and side effects curative effect to improve, and patients with coronary heart disease is mostly simultaneously with in various degree diabetes in addition, aspect medicine and diet restriction bigger, influence therapeutic effect.
Three, summary of the invention:
The objective of the invention is to overcome above-mentioned not enough problem, a kind of Chinese medicine electuary for the treatment of coronary heart disease is provided, pure Chinese medicinal preparation, prescription rationally evident in efficacyly have no side effect simultaneously.
The technical scheme that the present invention is adopted for achieving the above object is: the Chinese medicine electuary of treatment coronary heart disease is become to be grouped into by following traditional Chinese medicines: Radix Ginseng, Rhizoma Polygonati, Radix Glycyrrhizae, Ramulus Cinnamomi, Rhizoma Polygonati Odorati, the Radix Astragali, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Puerariae, Flos Chrysanthemi, Semen Plantaginis.
The weight portion of described Chinese medicine ingredients is:
Radix Ginseng 20-30, Rhizoma Polygonati 20-30, Radix Glycyrrhizae 10-20, Ramulus Cinnamomi 5-15, Rhizoma Polygonati Odorati 10-20, Radix Astragali 25-35, Radix Notoginseng 5-15, Radix Salviae Miltiorrhizae 20-30, Radix Puerariae 20-30, Flos Chrysanthemi 20-30, Semen Plantaginis 10-20.
The weight part ratio of described Chinese medicine ingredients is preferred: Radix Ginseng 25, Rhizoma Polygonati 25, Radix Glycyrrhizae 15, Ramulus Cinnamomi 10, Rhizoma Polygonati Odorati 15, the Radix Astragali 30, Radix Notoginseng 10, Radix Salviae Miltiorrhizae 25, Radix Puerariae 25, Flos Chrysanthemi 25, Semen Plantaginis 15.
The method for making of Chinese medicine preparation of the present invention is that the Chinese patent medicine grinding and processing raw material with above-mentioned prescription becomes powdered, per 10 grams, one bag hermetic package.Take after mixing it with hot water when taking, one time one bag, a twice-daily, 7 days is a course of treatment, is to reduce by half every day to take after the course of treatment.
The electuary that the present invention adopts natural pure Chinese herbal medicine to make, wherein Radix Ginseng have QI invigorating, multiple arteries and veins peace dirty, strengthen cardiac contractile force, blood sugar lowering, cholesterol regulating, collaborative insulin action, to coronary atherosclerosis and heart disease palace can the disease treatment effectively; Rhizoma Polygonati have suppress hyperglycemia, prevent arteriosclerosis, fatty liver is effective in cure; Radix Glycyrrhizae have quench the thirst, qualcomm meridian, sharp vim and vigour function; Radix Astragali energy stimulating central nervous system, the blood vessel dilating blood pressure lowering is strengthened cardiac contractile force; Radix Notoginseng is controlled the pain relieving of blood dissipating blood stasis for subsidence of swelling, and the Radix Notoginseng glycoside has cardiotonic, and the Radix Notoginseng flavone strengthens crown arteries and veins blood flow, reduces arterial pressure, slightly subtracts heart rate and myocardial oxygen consumption effect; Radix Salviae Miltiorrhizae has blood circulation promoting and blood stasis dispelling, and the relieving restlessness sedative action is used for coronary heart disease, angina pectoris, reduction serum, cholesterol and atherosclerosis; The Radix Puerariae blood sugar lowering, treatment hypertension, coronary heart disease, diseases such as angina pectoris; The Chinese medicine of reasonable compatibility of the present invention, toxicity is extremely low after testing, and human body safety is had no side effect, and is on probation through clinical patients, and treatment hypertension, heart disease, coronary heart disease are had good therapeutic effect, cure rate 98%.
Four, the specific embodiment:
Below in conjunction with specific embodiment the present invention is described in further detail:
Embodiment 1
Select raw material Radix Ginseng 25 grams, Rhizoma Polygonati 25 grams, Radix Glycyrrhizae 15 grams, Ramulus Cinnamomi 10 grams, Rhizoma Polygonati Odorati 15 grams, the Radix Astragali 30 grams, Radix Notoginseng 10 grams, Radix Salviae Miltiorrhizae 25 grams, Radix Puerariae 25 grams, Flos Chrysanthemi 25 grams, Semen Plantaginis 15 grams for use.The Chinese patent medicine grinding and processing raw material of above-mentioned prescription is become powdered, per 10 grams, one bag hermetic package.
Through the clinical patients applied statistics: male 20 examples, women 15 examples, 52 years old mean age, coronary heart disease initial stage patient 10 examples wherein, suffer from diabetes 20 examples of coronary heart disease are arranged simultaneously, severe patients with coronary heart disease 5 examples take after mixing it with hot water when taking, one time one bag, one twice-daily, 7 days is a course of treatment, cure rate 98%, be to reduce by half every day to take one course of treatment after curing, and the continuation of Zhi Yuing is not taken a course of treatment again by above-mentioned dose.
Embodiment 2
Select raw material Radix Ginseng 20 grams, Rhizoma Polygonati 25 grams, Radix Glycyrrhizae 16 grams, Ramulus Cinnamomi 12 grams, Rhizoma Polygonati Odorati 15 grams, the Radix Astragali 25 grams, Radix Notoginseng 15 grams, Radix Salviae Miltiorrhizae 30 grams, Radix Puerariae 25 grams, Flos Chrysanthemi 22 grams, Semen Plantaginis 12 grams for use.The Chinese patent medicine grinding and processing raw material of above-mentioned prescription is become powdered, per 10 grams, one bag hermetic package.
Embodiment 3
Select raw material Radix Ginseng 29 grams, Rhizoma Polygonati 22 grams, Radix Glycyrrhizae 13 grams, Ramulus Cinnamomi 8 grams, Rhizoma Polygonati Odorati 20 grams, the Radix Astragali 33 grams, Radix Notoginseng 7 grams, Radix Salviae Miltiorrhizae 22 grams, Radix Puerariae 20 grams, Flos Chrysanthemi 30 grams, Semen Plantaginis 17 grams for use.The Chinese patent medicine grinding and processing raw material of above-mentioned prescription is become powdered, per 10 grams, one bag hermetic package.
Claims (3)
1, the Chinese medicine electuary of treatment coronary heart disease, it is characterized in that: it is become to be grouped into by following traditional Chinese medicines: Radix Ginseng, Rhizoma Polygonati, Radix Glycyrrhizae, Ramulus Cinnamomi, Rhizoma Polygonati Odorati, the Radix Astragali, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Puerariae, Flos Chrysanthemi, Semen Plantaginis.
2, the Chinese medicine electuary of treatment coronary heart disease according to claim 1, it is characterized in that: the weight portion of Chinese medicine ingredients is: Radix Ginseng 20-30, Rhizoma Polygonati 20-30, Radix Glycyrrhizae 10-20, Ramulus Cinnamomi 5-15, Rhizoma Polygonati Odorati 10-20, Radix Astragali 25-35, Radix Notoginseng 5-15, Radix Salviae Miltiorrhizae 20-30, Radix Puerariae 20-30, Flos Chrysanthemi 20-30, Semen Plantaginis 10-20.
3, the Chinese medicine electuary of treatment coronary heart disease according to claim 1, it is characterized in that: the weight portion of Chinese medicine ingredients is: Radix Ginseng 25, Rhizoma Polygonati 25, Radix Glycyrrhizae 15, Ramulus Cinnamomi 10, Rhizoma Polygonati Odorati 15, the Radix Astragali 30, Radix Notoginseng 10, Radix Salviae Miltiorrhizae 25, Radix Puerariae 25, Flos Chrysanthemi 25, Semen Plantaginis 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100134299A CN101361902A (en) | 2008-09-25 | 2008-09-25 | Traditional Chinese medicine granules for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100134299A CN101361902A (en) | 2008-09-25 | 2008-09-25 | Traditional Chinese medicine granules for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101361902A true CN101361902A (en) | 2009-02-11 |
Family
ID=40388630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100134299A Pending CN101361902A (en) | 2008-09-25 | 2008-09-25 | Traditional Chinese medicine granules for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101361902A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210839A (en) * | 2011-05-29 | 2011-10-12 | 曹莹莹 | Traditional Chinese medicine capsule for treating coronary heart disease |
-
2008
- 2008-09-25 CN CNA2008100134299A patent/CN101361902A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210839A (en) * | 2011-05-29 | 2011-10-12 | 曹莹莹 | Traditional Chinese medicine capsule for treating coronary heart disease |
| CN102210839B (en) * | 2011-05-29 | 2012-10-10 | 李爱萍 | Traditional Chinese medicine capsule for treating coronary heart disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101011522B (en) | Chinese traditional medicine for treating cardiopathy | |
| CN107625836A (en) | A kind of Chinese medicine composition of anti-insomnia | |
| CN102940787A (en) | Traditional Chinese medicine for treating hypertension | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN1895547B (en) | Medicine for treating diabetes and its preparation | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN103182008A (en) | Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure | |
| CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102048939B (en) | Medicament for treating sinus bradycardia | |
| CN103041119A (en) | Traditional Chinese medicine for treating cardiac disease | |
| CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
| CN106421053A (en) | Traditional Chinese medicine capable of tonifying spleen and warming stomach | |
| CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101361902A (en) | Traditional Chinese medicine granules for treating coronary heart disease | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102172375A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN105435196A (en) | Externally-applied traditional Chinese medicine ointment for treating qi stagnation and blood stasis coronary angina pectoris with chronic gastritis and preparation method thereof | |
| CN102579688B (en) | Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN102397391A (en) | Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof | |
| CN106581425A (en) | Pharmaceutical composition for treating | |
| CN102068533A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20090211 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |